SCHEMBL4674366

SCHEMBL4674366

COC(=O)CCOc1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MMP1 P03956 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
LTA4H P09960 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42
GLA P06280 1/20 0.42
ADAMTS4 O75173 1/20 0.42
MMP2 P08253 1/20 0.42
MMP13 P45452 1/20 0.42
MMP14 P50281 1/20 0.42
ADAMTS5 Q9UNA0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4504044 0.84 ALDH1A1 (0.62) ALDH1A1MAPTLMNACYP2C9CYP2C19
SCHEMBL28851342 0.82 DYRK1A (0.43) DYRK1AALDH1A1MAPTLMNAKMT2A
SCHEMBL28801752 0.82 L3MBTL1 (0.59) ALDH1A1LMNAHTTMMP1LTA4H
SCHEMBL21991488 0.80 PTGS2 (0.58) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL11233455 0.80 MAPT (0.66) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL6393911 0.78 CA12 (0.47) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL10738896 0.78 L3MBTL1 (0.68) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL7697086 0.78 MAPT (0.53) DYRK1AALDH1A1MAPTLMNAHTT
SCHEMBL1932026 0.78 MAPT (0.53) ALDH1A1MAPTLMNAHTTKMT2A
SCHEMBL343527 0.78 IDO1 (0.56) ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482935-B1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER LAMBERT CO (US) 2008-08-20 EP disclosed
EP-1482935-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY Warner-Lambert Company LLC (US) 2004-12-08 EP disclosed
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation CHENG XUE-MIN (US) 2003-11-06 US disclosed
WO-2003074050-A1 THIAZOLE AND OXAZOLE DERIVATIVES WHICH MODULATE PPAR ACTIVITY WARNER-LAMBERT COMPANY LLC (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207924-A1 Compounds that modulate PPAR activity and methods of preparation PPARA, PPARD, PPARG DYRK1A 3675/4885ALDH1A1 886/4885MAPT 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.